Optimized psilocybin production in tryptophan catabolism‐repressed fungi

Optimized psilocybin production in tryptophan catabolism‐repressed fungi

Abstract The high therapeutic potential of psilocybin, a prodrug of the psychotropic psilocin, holds great promise for the treatment of mental disorders such as therapy‐refractory depression, alcohol use disorder and anorexia nervosa. Psilocybin has been designated a ‘Breakthrough Therapy’ by the US...

Full description

Saved in:

Bibliographic Details
Main Authors:	Slavica Janevska, Sophie Weiser, Ying Huang, Jun Lin, Sandra Hoefgen, Katarina Jojić, Amelia E. Barber, Tim Schäfer, Janis Fricke, Dirk Hoffmeister, Lars Regestein, Vito Valiante, Johann E. Kufs
Format:	Article
Language:	English
Published:	Wiley 2024-11-01
Series:	Microbial Biotechnology
Online Access:	https://doi.org/10.1111/1751-7915.70039
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The palmitoyl-CoA ligase Fum16 is part of a Fusarium verticillioides fumonisin subcluster involved in self-protection
by: Fabio Gherlone, et al.
Published: (2025-02-01)

Alzheimer’s disease-specific transcriptomic and epigenomic changes in the tryptophan catabolic pathway
by: Kyonghwan Choe, et al.
Published: (2024-11-01)

Indoleamine 2,3-dioxygenase-Mediated Tryptophan Catabolism Limits Experimental Abdominal Aortic Aneurysms
by: Baohui Xu, et al.
Published: (2024-01-01)

GnuR Represses the Expression of Glucose and Gluconate Catabolism in Pseudomonas putida KT2440
by: Wenbo Chen, et al.
Published: (2024-11-01)

Perturbations of tryptophan catabolism via the kynurenine pathway are associated with stage 2 postoperative outcomes in single ventricle heart disease
by: Jennifer Romanowicz, et al.
Published: (2024-11-01)

Refractory CRPS pain treated with psilocybin: A case report
by: David S. Jevotovsky, et al.
Published: (2024-09-01)

Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity
by: Kinderlehrer DA
Published: (2025-01-01)

Hyaluronan Synthesis, Catabolism, and Signaling in Neurodegenerative Diseases
by: Larry S. Sherman, et al.
Published: (2015-01-01)

Assessment of the number of catabolic genes of oil-contaminated soils
by: L.R. Biktasheva, et al.
Published: (2019-06-01)

The Repressed Keynes
by: Gustav A. Horn
Published: (2021-04-01)

The unique neural signature of your trip: Functional connectome fingerprints of subjective psilocybin experience
by: Hanna M. Tolle, et al.
Published: (2024-02-01)

Psilocybin and Motor Function: A Triple‐Blind, Dose‐Finding Study in Healthy Participants
by: Chiranth Bhagavan, et al.
Published: (2024-12-01)

Clinical Implications of Catabolic and Anabolic Bone Changes in Psoriatic Arthritis
by: Georg Schett
Published: (2024-01-01)

Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use
by: Jonathan Brett, et al.
Published: (2024-12-01)

Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals
by: Erin Wang, et al.
Published: (2024-11-01)

Tryptophan Metabolites in the Progression of Liver Diseases
by: Maria Reshetova, et al.
Published: (2024-11-01)

Preliminary analyses of tryptophan, kynurenine, and the kynurenine: Tryptophan ratio in plasma, as potential biomarkers for systemic chlamydial infections in koalas.
by: Chien-Jung Chen, et al.
Published: (2024-01-01)

Synthesis of β‐Alanine From Isoleucine and Propionate Catabolism via Aminotransferases
by: Margo H. Goldfarb, et al.
Published: (2024-12-01)

Influence Mechanism of Vermicompost with Different Maturity on Atrazine Catabolism and Bacterial Community
by: Luwen Zhang, et al.
Published: (2025-01-01)

Heme catabolism and heme oxygenase-1-expressing myeloid cells in pathophysiology
by: Francesca Maria Consonni, et al.
Published: (2024-10-01)

Surveillance, Normalisation, and Repression
by: Gilles Dorronsoro, et al.
Published: (2014-07-01)

Psilocybin-assisted psychotherapy as a potential treatment for eating disorders: a narrative review of preliminary evidence
by: Elena Koning, et al.
Published: (2024-12-01)

Prospective Preference Assessment for the Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN (PEACE-PAIN) Trial
by: Jiwon Lee, et al.
Published: (2024-12-01)

Glutathione has cell protective and anti-catabolic effects in articular cartilage without impairing the chondroanabolic phenotype
by: Svenja Maurer, et al.
Published: (2024-11-01)

Inositol pyrophosphate catabolism by three families of phosphatases regulates plant growth and development.
by: Florian Laurent, et al.
Published: (2024-11-01)

Bacterial Catabolism of Phthalates With Estrogenic Activity Used as Plasticisers in the Manufacture of Plastic Products
by: Rinita Dhar, et al.
Published: (2024-11-01)

Uncanny Beloveds and the Return of the Repressed
by: Maya Petrovich
Published: (2018-10-01)

YKL-40 as a Novel Factor Associated with Inflammation and Catabolic Mechanisms in Osteoarthritic Joints
by: Tuija Väänänen, et al.
Published: (2014-01-01)

CD73 alleviates osteoarthritis by maintaining anabolism and suppressing catabolism of chondrocytes extracellular matrix
by: Hu Guo, et al.
Published: (2024-11-01)

Hairy transcriptional repression targets and cofactor recruitment in Drosophila.
by: Daniella Bianchi-Frias, et al.
Published: (2004-07-01)

Drivers of methane-cycling archaeal abundances, community structure, and catabolic pathways in continental margin sediments
by: Longhui Deng, et al.
Published: (2025-02-01)

Alpinetin Attenuates Persistent Inflammation, Immune Suppression, and Catabolism Syndrome in a Septic Mouse Model
by: Yukun Liu, et al.
Published: (2021-01-01)

Rotavirus rewires host cell metabolic pathways toward glutamine catabolism for effective virus infection
by: Suvrotoa Mitra, et al.
Published: (2024-12-01)

Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design
by: Elena Koning, et al.
Published: (2024-12-01)

Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trial.
by: Shakila Meshkat, et al.
Published: (2025-01-01)

LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain
by: J Van Der Walt, et al.
Published: (2023-11-01)

Mechanism of Substrate Activation by Tryptophan Hydroxylase: A Computational Study
by: Dr. Thirakorn Mokkawes, et al.
Published: (2025-01-01)

Study of an arginine- and tryptophan-rich antimicrobial peptide in peri-implantitis
by: Qian Zhang, et al.
Published: (2025-01-01)

Biological function of d-tryptophan: a bibliometric analysis and review
by: Fei Wang, et al.
Published: (2025-01-01)

Peripheral tryptophan-kynurenine pathway dysfunction in first-episode schizophrenia
by: Mian Li, et al.
Published: (2025-01-01)